baking resize 2

Combination Therapies Mix Things Up at EORTC

Crown Bioscience recently attended the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona. As well as manning a popular booth and presenting four scientific posters, we also reviewed the best of the drug development research on display. A particularly hot topic at this year’s conference was combination therapies.

Three cups

Finding the Best Treatment for Ovarian Cancer

The early detection and correct diagnosis of cancer is important to optimize treatment regimens, and to give patients the best chance of response and survival. Diagnosis of ovarian cancer is often difficult, as is correctly staging the disease, which can lead to patients not receiving the best treatment for their cancer type. A new test… Read more »

doorknocker resize2

Opportunity Knocks for Oncology Clinical Trials

Patient participation in oncology clinical trials is very low due to patient concerns including worries over experimental drug effectiveness and uncertainty around joining clinical trials versus using a standard therapy. New methods are needed to encourage higher enrolment, one of which is ‘window of opportunity trials’ which use gaps in early standard of care treatment… Read more »

seesaw resized

The Ups and Downs of an Angiogenesis Inhibitor

Targeted therapies can often be used in multiple different cancer types, dependent on multiple cancers all having the same target, such as an upregulated or overexpressed protein, or all having the same mutation. One example of this is VEGF and VEGF receptor (VEGFR) inhibitors, which act as antiangiogenic agents and block the formation of new… Read more »